Jiang Cao

4.4k total citations
152 papers, 2.3k citations indexed

About

Jiang Cao is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Jiang Cao has authored 152 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 48 papers in Hematology and 42 papers in Molecular Biology. Recurrent topics in Jiang Cao's work include CAR-T cell therapy research (30 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Immune Cell Function and Interaction (14 papers). Jiang Cao is often cited by papers focused on CAR-T cell therapy research (30 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Immune Cell Function and Interaction (14 papers). Jiang Cao collaborates with scholars based in China, United States and Panama. Jiang Cao's co-authors include Kailin Xu, Lingyu Zeng, Hai Cheng, Yì Wáng, Su Zeng, Wei Sang, Li Li, Zhiling Yan, Bin Pan and Junnian Zheng and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jiang Cao

141 papers receiving 2.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jiang Cao 757 743 396 374 247 152 2.3k
Frances L. Johnson 319 0.4× 941 1.3× 352 0.9× 406 1.1× 180 0.7× 45 2.5k
Qi Cao 314 0.4× 824 1.1× 211 0.5× 169 0.5× 299 1.2× 74 2.4k
Shozo Nishida 974 1.3× 1.6k 2.1× 324 0.8× 250 0.7× 727 2.9× 171 3.6k
David E. Morse 784 1.0× 1.1k 1.5× 303 0.8× 114 0.3× 274 1.1× 19 2.6k
Carla Costa 843 1.1× 1.6k 2.1× 116 0.3× 271 0.7× 797 3.2× 29 2.8k
Christoph Otto 382 0.5× 869 1.2× 78 0.2× 269 0.7× 334 1.4× 133 2.8k
Li Cai 807 1.1× 1.7k 2.3× 95 0.2× 323 0.9× 802 3.2× 159 3.3k
Gulnaz Begum 404 0.5× 929 1.3× 687 1.7× 327 0.9× 160 0.6× 48 2.5k
Norifumi Urao 210 0.3× 1.1k 1.5× 174 0.4× 439 1.2× 240 1.0× 49 2.3k
Hua Zhu 219 0.3× 1.0k 1.4× 166 0.4× 576 1.5× 481 1.9× 92 2.5k

Countries citing papers authored by Jiang Cao

Since Specialization
Citations

This map shows the geographic impact of Jiang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Cao more than expected).

Fields of papers citing papers by Jiang Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Cao. The network helps show where Jiang Cao may publish in the future.

Co-authorship network of co-authors of Jiang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Cao. A scholar is included among the top collaborators of Jiang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Cao. Jiang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chao, et al.. (2025). Ablation of atrial flutter related to the left atrial appendage occluder. HeartRhythm Case Reports. 11(5). 446–449.
2.
Wang, Xiangmin, Qing Zhang, Hongyuan Zhou, et al.. (2024). Impact of tocilizumab on anti‐CD19 chimeric antigen receptor T‐cell therapy in B‐cell acute lymphoblastic leukemia. Cancer. 130(15). 2660–2669. 3 indexed citations
3.
Zhang, Xiaoxue, Xu Wang, Xuan Zhao, et al.. (2024). In vivo manufacture and manipulation of CAR-T cells for better druggability. Cancer and Metastasis Reviews. 43(3). 1075–1093. 12 indexed citations
4.
Cao, Jiang, et al.. (2024). Necroptosis pathway emerged as potential diagnosis markers in spinal cord injury. Journal of Cellular and Molecular Medicine. 28(7). e18219–e18219. 4 indexed citations
5.
Liu, Yang, Nian Li, Ying Wang, et al.. (2023). A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells. Frontiers in Immunology. 14. 1169071–1169071. 17 indexed citations
6.
Chang, Jie, Zhanyang Qian, Binyu Wang, et al.. (2023). Transplantation of A2 type astrocytes promotes neural repair and remyelination after spinal cord injury. Cell Communication and Signaling. 21(1). 37–37. 56 indexed citations
7.
Li, Qingqing, Zhenfei Huang, Jiang Cao, et al.. (2022). A comparison of robot-assisted and fluoroscopy-assisted kyphoplasty in the treatment of multi-segmental osteoporotic vertebral compression fractures. Journal of Biomedical Research. 36(3). 208–208. 12 indexed citations
8.
Hong, Fei, Ming Shi, Jiang Cao, et al.. (2021). Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia. Journal of Cellular and Molecular Medicine. 25(24). 11063–11074. 23 indexed citations
9.
Zhang, Huihui, Fanlin Li, Jiang Cao, et al.. (2021). A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity. Science Translational Medicine. 13(578). 77 indexed citations
10.
Chen, Wei, Yan Xu, Wentong Guo, et al.. (2021). Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance. International Immunopharmacology. 94. 107503–107503. 5 indexed citations
11.
Wang, Boyao, Jiang Cao, Jie Chang, et al.. (2021). Effectiveness of Tirobot-assisted vertebroplasty in treating thoracolumbar osteoporotic compression fracture. Journal of Orthopaedic Surgery and Research. 16(1). 65–65. 32 indexed citations
12.
Zhang, Huihui, Rong Wang, Tingting Shao, et al.. (2019). High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia. Journal of Translational Medicine. 17(1). 106–106. 11 indexed citations
13.
Cao, Jiang, et al.. (2019). Clinical observation of amitriptyline combined with Xiaoyao Powder in the treatment of postpartum depression. Zhongguo jiceng yiyao. 26(19). 2332–2335. 1 indexed citations
14.
Yu, Di, Bin Zhang, Huan-Xin Zhang, et al.. (2018). [Risk Factors and Prognosis of Hepatic cGVHD after Allogeneic Hematopoietic Stem Cell Transplantation].. PubMed. 26(4). 1174–1179. 1 indexed citations
15.
Yang, Chen, Tingting Shao, Huihui Zhang, et al.. (2018). MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. Journal of Translational Medicine. 16(1). 267–267. 16 indexed citations
16.
Ali, Muhammad, Muhammad Saif Ur Rahman, Jiang Cao, & Ping Yuan. (2017). Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario. 3 Biotech. 7(4). 251–251. 59 indexed citations
17.
18.
Yan, Zhiling, Zhenyu Li, Huanxin Zhang, et al.. (2015). [Efficacy of high-dose dexamethasone plus low-dose rituximab as a second-line treatment in 65 patients with primary immune thrombocytopenia].. PubMed Central. 36(3). 206–9. 2 indexed citations
19.
Su, Xingyun, et al.. (2014). ER-α36: a novel biomarker and potential therapeutic target in breast cancer. SHILAP Revista de lepidopterología. 7 indexed citations
20.
Zeng, Lingyu, Ting Fang, Bin Pan, et al.. (2013). A Murine Model of Hepatic Veno-occlusive Disease Induced by Allogeneic Hematopoietic Stem Cell Transplantation. Cell Biochemistry and Biophysics. 67(3). 939–948. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frances L. Johnson Breakdown of academic impact, for papers by Qi Cao Breakdown of academic impact, for papers by Shozo Nishida Breakdown of academic impact, for papers by David E. Morse Breakdown of academic impact, for papers by Carla Costa Breakdown of academic impact, for papers by Christoph Otto Breakdown of academic impact, for papers by Li Cai Breakdown of academic impact, for papers by Gulnaz Begum Breakdown of academic impact, for papers by Norifumi Urao Breakdown of academic impact, for papers by Hua Zhu
Rankless by CCL
2026